IRIS
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.707
AS - Asia 4.307
EU - Europa 3.401
SA - Sud America 516
Continente sconosciuto - Info sul continente non disponibili 183
AF - Africa 151
OC - Oceania 32
Totale 14.297
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.539
CN - Cina 2.133
SG - Singapore 933
IE - Irlanda 802
HK - Hong Kong 450
IT - Italia 434
UA - Ucraina 389
RU - Federazione Russa 369
DE - Germania 368
VN - Vietnam 360
BR - Brasile 358
FI - Finlandia 353
FR - Francia 209
GB - Regno Unito 189
SE - Svezia 107
BD - Bangladesh 103
CA - Canada 102
IN - India 85
ZA - Sudafrica 79
AR - Argentina 65
IQ - Iraq 41
MX - Messico 36
BE - Belgio 35
JP - Giappone 31
PL - Polonia 26
AT - Austria 23
EC - Ecuador 23
CO - Colombia 22
NL - Olanda 22
AU - Australia 19
PK - Pakistan 19
TR - Turchia 19
PH - Filippine 17
VE - Venezuela 17
MA - Marocco 16
ES - Italia 15
KE - Kenya 12
NZ - Nuova Zelanda 12
UZ - Uzbekistan 12
MY - Malesia 11
TN - Tunisia 11
CL - Cile 10
SA - Arabia Saudita 10
ID - Indonesia 9
JO - Giordania 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
CR - Costa Rica 7
DZ - Algeria 7
ET - Etiopia 7
KR - Corea 7
KZ - Kazakistan 7
PE - Perù 7
RO - Romania 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
EG - Egitto 6
EU - Europa 6
IR - Iran 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
DK - Danimarca 5
IL - Israele 5
KG - Kirghizistan 5
NP - Nepal 5
PY - Paraguay 5
GR - Grecia 4
LT - Lituania 4
LU - Lussemburgo 4
PT - Portogallo 4
JM - Giamaica 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
TH - Thailandia 3
BB - Barbados 2
CW - ???statistics.table.value.countryCode.CW??? 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LY - Libia 2
NO - Norvegia 2
QA - Qatar 2
UY - Uruguay 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
GN - Guinea 1
GP - Guadalupe 1
Totale 14.108
Salva come PNG Salva come JPEG
Città #
Dublin 799
Chandler 708
Ashburn 514
San Jose 502
Jacksonville 494
Singapore 475
Hong Kong 440
Nanjing 436
Beijing 392
Dallas 383
Boardman 207
Council Bluffs 199
Nanchang 172
Wilmington 145
Ho Chi Minh City 141
Princeton 140
Lawrence 138
Shenyang 135
Los Angeles 131
Lauterbourg 129
Changsha 121
Helsinki 120
Hebei 119
Ann Arbor 118
Jiaxing 108
Milan 104
New York 103
Medford 97
Hanoi 83
Johannesburg 72
Hangzhou 71
Shanghai 70
Pavia 66
Tianjin 63
Buffalo 61
Redondo Beach 61
Moscow 59
Munich 49
Toronto 44
São Paulo 40
Santa Clara 39
Woodbridge 36
Frankfurt am Main 32
Orem 31
Tokyo 31
Brussels 29
Houston 28
Norwalk 28
Seattle 28
Nuremberg 24
Verona 24
Falkenstein 23
Fairfield 21
London 21
Turku 21
Brooklyn 20
Chicago 20
Warsaw 20
Ottawa 19
Baghdad 18
Denver 18
Zhengzhou 18
Atlanta 17
Chennai 17
Des Moines 17
San Francisco 17
Kunming 16
Manchester 16
Columbus 15
Trieste 15
Boston 14
Falls Church 14
Haiphong 14
Phoenix 14
The Dalles 14
Guangzhou 13
Bergamo 12
City of London 12
Montreal 12
Pune 12
Stockholm 12
Amsterdam 11
Florence 11
Jinan 11
Nairobi 11
Tashkent 11
Mexico City 10
Belo Horizonte 9
Buenos Aires 9
Da Nang 9
Dhaka 9
Hải Dương 9
Piscataway 9
Poplar 9
Quito 9
Rochester 9
Vienna 9
Amman 8
Berlin 8
Miami 8
Totale 9.310
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 306
A first update on mapping the human genetic architecture of COVID-19 209
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 188
Long QT and short QT syndromes. 164
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 149
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 148
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 144
Gene symbol: KCNH2 141
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 139
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 138
FGF12 is a candidate Brugada syndrome locus. 134
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 134
Long QT syndrome-associated mutations in intrauterine fetal death. 131
AKAP9 is a genetic modifier of congenuital Long-QT Syndrome type 1 129
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 124
The genetics underlying acquired long QT syndrome: impact for genetic screening. 123
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 120
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 119
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 119
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 117
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 117
Cardiac potassium channel dysfunction in sudden infant death syndrome. 116
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 116
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 115
All LQT3 patients need an ICD. True or false? 115
Inherited cardiac arrhythmia syndrome. Role of potassium channels 115
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 115
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 115
Cardiac sodium channel dysfunction in sudden infant death syndrome. 114
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 114
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 114
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 114
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 113
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 113
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 112
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 111
QT lungo, sindrome del 110
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 108
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. 108
Prevalence of the congenital long-QT syndrome. 107
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 107
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 106
Brugada and Long QT Syndrome are two different diseases: True or False? 105
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 105
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 104
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 104
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 104
The ICD for the long QT syndrome: which indications, complications, and results? 103
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 103
Can a message from the dead save lives? 103
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 103
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome 101
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. 100
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 100
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 99
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 99
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. 99
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 99
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 99
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 99
Congenital long QT and short QT syndromes 98
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 98
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 97
Idiopathic Ventricular Fibrillation. 96
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features 96
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 94
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population 94
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. 93
Gene symbol: SCN5A 92
QTc behavior during exercise and genetic testing for the long-QT syndrome. 92
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 92
Clinical implications for patients with Long QT Syndrome who experience a cardiac event during infancy 92
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 90
Calmodulin mutations associated with recurrent cardiac arrest in infants. 90
Gene symbol: KCNH2 89
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients. 89
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. 88
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. 88
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. 88
The Long QT Syndrome 87
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 87
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. 87
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients 87
High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. 87
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 86
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 86
Gene symbol: KCNH2 86
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 86
Gene symbol: KCNH2. 85
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. 85
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. 85
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. 85
Ion channel diseases in children: manifestations and management. 83
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 82
Gene expression and arrhythmic risk. 81
Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. 81
Gene symbol: KCNQ1. 81
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 80
Congenital Short QT Syndrome 80
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. 79
Totale 10.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022564 0 5 33 7 13 18 7 43 34 6 90 308
2022/20232.247 232 152 27 246 194 221 2 108 907 6 124 28
2023/2024820 92 136 22 53 73 196 23 77 5 30 65 48
2024/20252.079 45 178 62 51 46 116 103 174 526 74 220 484
2025/20264.779 376 391 519 429 622 202 878 225 426 330 206 175
2026/2027332 103 229 0 0 0 0 0 0 0 0 0 0
Totale 14.297